Recursion Pharmaceuticals, Inc. (RXRX)
4.11
-0.02
(-0.48%)
USD |
NASDAQ |
Dec 30, 16:00
4.12
+0.01
(+0.24%)
Pre-Market: 08:58
Recursion Pharmaceuticals Free Cash Flow: -450.20M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Hims & Hers Health, Inc. | 116.09M |
| ACADIA Pharmaceuticals, Inc. | 98.97M |
| Amicus Therapeutics, Inc. | 9.691M |
| iBio, Inc. | -17.30M |
| GT Biopharma, Inc. | -11.36M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -117.36M |
| Cash from Investing (Quarterly) | -2.549M |
| Cash from Financing (Quarterly) | 251.34M |
| Free Cash Flow Per Share (Quarterly) | -0.2631 |
| Free Cash Flow to Equity (Quarterly) | -111.90M |
| Free Cash Flow to Firm (Quarterly) | -116.77M |
| Free Cash Flow Yield | -27.33% |